Goldman Sachs Group »

Lyell Immunopharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.0M 97k 30.78

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Vanguard Group
Foresite Capital Management IV
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Geode Capital Management
Sc China Holding
Millennium Management
Goldman Sachs Group

View all funds holding Lyell Immunopharma